Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Colorcon
Mallinckrodt
Deloitte
Cipla
Queensland Health
Moodys
US Department of Justice

Generated: July 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017078

« Back to Dashboard

NDA 017078 describes DEXEDRINE, which is a drug marketed by Impax Labs Inc and Glaxosmithkline and is included in three NDAs. It is available from three suppliers. Additional details are available on the DEXEDRINE profile page.

The generic ingredient in DEXEDRINE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 017078
Tradename:DEXEDRINE
Applicant:Impax Labs Inc
Ingredient:dextroamphetamine sulfate
Patents:0
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017078
Medical Subject Heading (MeSH) Categories for 017078
Suppliers and Packaging for NDA: 017078
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078 NDA AUTHORIZED GENERIC Impax Generics 0115-1702 N 0115-1702-10
DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078 NDA AUTHORIZED GENERIC Impax Generics 0115-1703 N 0115-1703-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength15MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Mallinckrodt
Accenture
QuintilesIMS
Covington
US Army
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.